Unmasking the janus face of myoglobin in health and disease

Journal of Experimental Biology

Volumn 213, Issue 16, 2010, Pages 2734-2740

  Hendgen Cotta, U B ^a   Flogel U ^b   Kelm, M ^a   Rassaf, T ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Hypoxia; Ischemia reperfusion; Myoglobin; Nitric oxide; Nitrite; Normoxia

Indexed keywords

MYOGLOBIN; NITRIC OXIDE; OXYGEN; REACTIVE OXYGEN METABOLITE;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; GENERAL ASPECTS OF DISEASE; GENETICS; HEART MUSCLE; HUMAN; KIDNEY FAILURE; METABOLISM; PARASITOSIS; PATHOLOGY; PROTEIN CONFORMATION; REPERFUSION INJURY; REVIEW; DISEASES;

ANIMALS; DISEASE; HUMANS; KIDNEY FAILURE; MODELS, MOLECULAR; MYOCARDIUM; MYOGLOBIN; NITRIC OXIDE; OXYGEN; PARASITIC DISEASES; PROTEIN CONFORMATION; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; RENAL INSUFFICIENCY;

EID: 77955636089     PISSN: 00220949     EISSN: None     Source Type: Journal    
DOI: 10.1242/jeb.041178     Document Type: Review

References (107)

1. Adams, L. B., Hibbs, J. B., Jr, Taintor, R. R. and Krahenbuhl, J. L. (1990). Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J. Immunol. 144, 2725-2729.
2. Almeida, I. C., Camargo, M. M., Procópio, D. O., Silva, L. S., Mehlert, A., Travassos, L. R., Gazzinelli, R. T. and Ferguson, M. A. (2000). Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J. 19, 1476-1485.
3. Antonini, E. and Brunori, M. (1971). Hemoglobin and Myoglobin in their Reactions with Ligands. Amsterdam: North-Holland Publishing Company.
4. Arduini, A., Eddy, L. and Hochstein, P. (1990). Detection of ferryl myoglobin in the isolated ischemic rat heart. Free Radic. Biol. Med. 9, 511-513.
5. Ascenzi, P., Salvati, L. and Brunori, M. (2001). Does myoglobin protect Trypanosoma cruzi from the antiparasitic effects of nitric oxide? FEBS Lett. 501, 103-105.
6. Ascenzi, P., Bocedi, A. and Gradoni, L. (2005). Do neuroglobin and myoglobin protect Toxoplasma gondii from nitrosative stress? IUBMB Life 57, 689-691.
7. Austin, R. H., Beeson, K. W., Eisenstein, L., Frauenfelder, H. and Gunsalus, I. C. (1975). Dynamics of ligand binding to myoglobin. Biochemistry 14, 5355-5373.
8. Awad, J. A., Morrow, J. D., Takahashi, K. and Roberts, L. J. (1993). Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma. J. Biol. Chem. 268, 4161-4169.
9. Bolli, R. (2001). Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J. Mol. Cell. Cardiol. 33, 1897-1918.
10. Brunet, L. R. (2001). Nitric oxide in parasitic infections. Int. Immunopharmacol. 1, 1457-1467.
11. Brunori, M. (2001). Nitric oxide moves myoglobin centre stage. Trends Biochem. Sci. 26, 209-210.
12. Brunori, M., Vallone, B., Cutruzzola, F., Travaglini-Allocatelli, C., Berendzen, J., Chu, K., Sweet, R. M. and Schlichting, I. (2000). The role of cavities in protein dynamics: crystal structure of a photolytic intermediate of a mutant myoglobin. Proc. Natl. Acad. Sci. USA 97, 2058-2063.
13. Bryan, N. S., Fernandez, B. O., Bauer, S. M., Garcia-Saura, M. F., Milsom, A. B., Rassaf, T., Maloney, R. E., Bharti, A., Rodriguez, J. and Feelisch, M. (2005). Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat. Chem. Biol. 1, 290-297.
14. Burwell, L. S., Nadtochiy, S. M., Tompkins, A. J., Young, S. and Brookes, P. S. (2006). Direct evidence for S-nitrosation of mitochondrial complex I. Biochem. J. 394, 627-634.
15. Chen, Q., Moghaddas, S., Hoppel, C. L. and Lesnefsky, E. J. (2006). Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion. J. Pharmacol. Exp. Ther. 319, 1405-1412.
16. Cossins, A. R., Williams, D. R., Foulkes, N. S., Berenbrink, M. and Kipar, A. (2009). Diverse cell-specific expression of myoglobin isoforms in brain, kidney, gill and liver of the hypoxia-tolerant carp and zebrafish. J. Exp. Biol. 212, 627-638.
17. Dantsker, D., Samuni, U., Friedman, A. J., Yang, M., Ray, A. and Friedman, J. M. (2002). Geminate rebinding in trehalose-glass embedded myoglobins reveals residue-specific control of intramolecular trajectories. J. Mol. Biol. 315, 239-251.
18. Dee, G., Rice-Evans, C., Obeyesekera, S., Meraji, S., Jacobs, M. and Bruckdorfer, K. R. (1991). The modulation of ferryl myoglobin formation and its oxidative effects on low density lipoproteins by nitric oxide. FEBS Lett. 294, 38-42.
19. Detweiler, C. D., Deterding, L. J., Tomer, K. B., Chignell, C. F., Germolec, D. and Mason, R. P. (2002). Immunological identification of the heart myoglobin radical formed by hydrogen peroxide. Free Radic. Biol. Med. 33, 364-369.
20. Ferrara, N., Gerber, H. P. and LeCouter, J. (2003). The biology of VEGF and its receptors. Nat. Med. 9, 669-676.
21. Flögel, U., Merx, M. W., Gödecke, A., Decking, U. K. and Schrader, J. (2001). Myoglobin: a scavenger of bioactive NO. Proc. Natl. Acad. Sci. USA 98, 735-740.
22. Flögel, U., Gödecke, A., Klotz, L. O. and Schrader, J. (2004). Role of myoglobin in the antioxidant defense of the heart. FASEB J. 18, 1156-1158.
23. Flögel, U., Fago, A. and Rassaf, T. (2010). Keeping the heart in balance: the functional interactions of myoglobin with nitrogen oxides. J. Exp. Biol. 213, 2726-2733.
24. Flonta, S. E., Arena, S., Pisacane, A., Michieli, P. and Bardelli, A. (2009). Expression and functional regulation of myoglobin in epithelial cancers. Am. J. Pathol. 175, 201-206.
25. Forstermann, U., Kleinert, H., Gath, I., Schwarz, P., Closs, E. I. and Dun, N. J. (1995). Expression and expressional control of nitric oxide synthases in various cell types. Adv. Pharmacol. 34, 171-186.
26. Fraser, J., de Mello, L. V., Ward, D., Rees, H. H., Williams, D. R., Fang, Y., Brass, A., Gracey, A. Y. and Cossins, A. R. (2006). Hypoxia-inducible myoglobin expression in nonmuscle tissues. Proc. Natl. Acad. Sci. USA 103, 2977-2981.
27. Frauenfelder, H. and McMahon, B. H. (2001). Relaxations and fluctuations in myoglobin. Biosystems 62, 3-8.
28. Frauenfelder, H., McMahon, B. H., Austin, R. H., Chu, K. and Groves, J. T. (2001). The role of structure, energy landscape, dynamics, and allostery in the enzymatic function of myoglobin. Proc. Natl. Acad. Sci. USA 98, 2370-2374.
29. Gagne, S. S. (2001). Toxoplasmosis. Prim. Care Update Ob. Gyns. 8, 122-126.
30. Galaris, D., Eddy, L., Arduini, A., Cadenas, E. and Hochstein, P. (1989). Mechanisms of reoxygenation injury in myocardial infarction: implications of a myoglobin redox cycle. Biochem. Biophys. Res. Commun. 160, 1162-1168.
31. Galluzzo, M., Pennacchietti, S., Rosano, S., Comoglio, P. M. and Michieli, P. (2009). Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis. J. Clin. Invest. 119, 865-875.
32. Garry, D. J., Ordway, G. A., Lorenz, J. N., Radford, N. B., Chin, E. R., Grange, R. W., Bassel-Duby, R. and Williams, R. S. (1998). Mice without myoglobin. Nature 395, 905-908.
33. George, P. and Irvine, D. H. (1951). Reaction of methmyoglobin with hydrogen peroxide. Nature 168, 164-165.
34. Gladwin, M. T. (2005). Nitrite as an intrinsic signaling molecule. Nat. Chem. Biol. 1, 245-246.
35. Gödecke, A., Flögel, U., Zanger, K., Ding, Z., Hirchenhain, J., Decking, U. K. and Schrader, J. (1999). Disruption of myoglobin in mice induces multiple compensatory mechanisms. Proc. Natl. Acad. Sci. USA 96, 10495-10500.
36. Gödecke, A., Molojavyi, A., Heger, J., Flögel, U., Ding, Z., Jacoby, C. and Schrader, J. (2003). Myoglobin protects the heart from inducible nitric-oxide synthase (iNOS)-mediated nitrosative stress. J. Biol. Chem. 278, 21761-21766.
37. Günther, H. (1921). Über den Muskelfarbstoff. Virchows Arch. 230, 146-178.
38. Hagler, L., Coppes, R. I., Jr and Herman, R. H. (1979). Metmyoglobin reductase. Identification and purification of a reduced nicotinamide adenine dinucleotidedependent enzyme from bovine heart which reduces metmyoglobin. J. Biol. Chem. 254, 6505-6514.
39. Harel, S. and Kanner, J. (1988). The generation of ferryl or hydroxyl radicals during interaction of haemproteins with hydrogen peroxide. Free Radic. Res. Commun. 5, 21-33.
40. Harris, A. L. (2002). Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Cancer 2, 38-47.
41. Hazarika, S., Angelo, M., Li, Y., Aldrich, A. J., Odronic, S. I., Yan, Z., Stamler, J. S. and Annex, B. H. (2008). Myocyte specific overexpression of myoglobin impairs angiogenesis after hind-limb ischemia. Arterioscler. Thromb. Vasc. Biol. 28, 2144-2150.
42. Hendgen-Cotta, U. B., Merx, M. W., Shiva, S., Schmitz, J., Becher, S., Klare, J. P., Steinhoff, H.-J., Gödecke, A., Schrader, J., Gladwin, M. T. et al. (2008). Nitrite reductase activity regulates respiration and cellular viability in myocardial ischemiareperfusion injury. Proc. Natl. Acad. Sci. USA 22, 10256-10261.
43. Herold, S. and Rehmann, F. J. (2001). Kinetic and mechanistic studies of the reactions of nitrogen monoxide and nitrite with ferryl myoglobin. J. Biol. Inorg. Chem. 6, 543-555.
44. Heusch, G. (1998). Hibernating myocardium. Physiol. Rev. 78, 1055-1085.
45. Holmes, K., Roberts, O. L., Thomas, A. M. and Cross, M. J. (2007). Vascular endothelial growth factor receptor-2: structure, function, intracellularsignalling and therapeutic inhibition. Cell. Signal. 19, 2003-2012.
46. Holt, S., Reeder, B., Wilson, M., Harvey, S., Morrow, J. D., Roberts, L. J., 2nd and Moore, K. (1999). Increased lipid peroxidation in patients with rhabdomyolysis. Lancet 353, 1241.
47. James, S. L. (1995). Role of nitric oxide in parasitic infections. Microbiol. Rev. 59, 533-547.
48. Jones, S. P. and Bolli, R. (2006). The ubiquitous role of nitric oxide in cardioprotection, J. Mol. Cell. Cardiol. 40, 16-23.
49. Kallergi, G., Markomanolaki, H., Giannoukaraki, V., Papadaki, M. A., Strati, A., Lianidou, E., Georgoulias, V., Mavroudis, D. and Agelaki, S. (2009). Hypoxiainducible factor-1 alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients. Breast Cancer Res. 11, R84.
50. Kanatous, S. B., Hawke, T. J., Trumble, S. J., Pearson, L. E., Watson, R. R., Garry, D. J., Williams, T. M. and Davis, R. W. (2008). The ontogeny of aerobic and diving capacity in the skeletal muscles of Weddell seals. J. Exp. Biol. 211, 2559-2565.
51. Kanatous, S. B., Mammen, P. P., Rosenberg, P. B., Martin, C. M., White, M. D., DiMaio, J. M., Huang, G., Muallem, S. and Garry, D. J. (2009). Hypoxia reprograms calcium signaling and regulates myoglobin expression. Am. J. Physiol. 296, C393-C402.
52. Kendrew, J. C. (1963). Myoglobin and the structure of proteins. Science 139, 1259-1266.
53. Kendrew, J. C., Dickerson, R. E., Strandberg, B. E., Hart, R. G., Davies, D. R., Phillips, D. C. and Shore, V. C. (1960). Structure of myoglobin: a three-dimensional Fourier synthesis at 2 Å resolution. Nature 185, 422-427.
54. Kooyman, G. L. and Ponganis, P. J. (1998). The physiological basis of diving to depth: birds and mammals. Annu. Rev. Physiol. 60, 19-32.
55. Luczak, K., Balcerczyk, A., Soszynski, M. and Bartosz, G. (2004). Low concentration of oxidant and nitric oxide donors stimulate proliferation of human endothelial cells in vitro. Cell Biol. Int. 28, 483-486.
56. Mammen, P. P., Kanatous, S. B., Yuhanna, I. S., Shaul, P. W., Garry, M. G., Balaban, R. S. and Garry, D. J. (2003). Hypoxia-induced left ventricular dysfunction in myoglobin deficient mice. Am. J. Physiol. 285, H2132-H2141.
57. Merx, M. W., Flögel, U., Stumpe, T., Gödecke, A., Decking, U. K. and Schrader, J. (2001). Myoglobin facilitates oxygen diffusion. FASEB J. 15, 1077-1079.
58. Millikan, G. A. (1939). Muscle hemoglobin. Physiol. Rev. 19, 503-523.
59. Moore, K. P., Holt, S. G., Patel, R. P., Svistunenko, D. A., Zackert, W., Goodier, D., Reeder, B. J., Clozel, M., Anand, R., Cooper, C. E. et al. (1998). A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J. Biol. Chem. 273, 31731-31737.
60. Mörner, K. A. H. (1897). Beobachtungen über den Muskelfarbstoff. Nord. Med. Ark. 30, 1-8.
61. Murohara, T., Asahara, T., Silver, M., Bauters, C., Masuda, H., Kalka, C., Kearney, M., Chen, D., Symes, J. F., Fishman, M. C. et al. (1998). Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101, 2567-2578.
62. Murray, H. W. and Nathan, C. F. (1999). Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J. Exp. Med. 189, 741-746.
63. Namba, T., Koike, H., Murakami, K., Aoki, M., Makino, H., Hashiya, N., Ogihara, T., Kaneda, Y., Kohno, M. and Morishita, R. (2003). Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model. Circulation 108, 2250-2257.
64. Nienhaus, K., Deng, P., Kriegl, J. M. and Nienhaus, G. U. (2003a). Structural dynamics of myoglobin: the effect of internal cavities on ligand migration and binding. Biochemistry 42, 9647-9658.
65. Nienhaus, K., Deng, P., Kriegl, J. M. and Nienhaus, G. U. (2003b). Structural dynamics of myoglobin: spectroscopic and structural characterization of ligand docking sites in myoglobin mutant L29W. Biochemistry 42, 9633-9646.
66. Nienhaus, K., Palladino, P. and Nienhaus, G. U. (2008). Structural dynamics of myoglobin: FTIR-TDS study of NO migration and binding. Biochemistry 47, 935-948.
67. Nitta, T., Xundi, X., Hatano, E., Yamamoto, N., Uehara, T., Yoshida, M., Harada, N., Honda, K., Tanaka, A., Sosnowski, D. et al. (2003). Myoglobin gene expression attenuates hepatic ischemia reperfusion injury. J. Surg. Res. 110, 322-331.
68. North, S., Moenner, M. and Bikfalvi, A. (2005). Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors. Cancer Lett. 218, 1-14.
69. 2: toxicological implications. Free Radic. Biol. Med. 21, 35-41.
70. Ostermann, A., Waschipky, R., Parak, F. G. and Nienhaus, G. U. (2000). Ligand binding and conformational motions in myoglobin. Nature 404, 205-208.
71. Patel, R. P., Diczfalusy, U., Dzeletovic, S., Wilson, M. T. and Darley-Usmar, V. M. (1996). J. Lipid Res. 37, 2361-2371.
72. Perutz, M. F. and Matthews, F. S. (1966). An x-ray study of azide methaemoglobin. J. Mol. Biol. 21, 199-202.
73. Phillips, S. E. (1980). Structure and refinement of oxymyoglobin at 1.6 Å resolution. J. Mol. Biol. 142, 531-554.
74. Qiu, Y., Sutton, L. and Riggs, A. F. (1998). Identification of myoglobin in human smooth muscle. J. Biol. Chem. 273, 23426-23432.
75. Quintero, M., Brennan, P. A., Thomas, G. J. and Moncada, S. (2006). Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1alpha in cancer: role of free radical formation. Cancer Res. 66, 770-774.
76. Rassaf, T., Flögel, U., Drexhage, C., Hendgen-Cotta, U., Kelm, M. and Schrader, J. (2007). Nitrite reductase function of deoxymyoglobin. Oxygen sensor and regulator of cardiac energetics and function. Circ. Res. 100, 1749-1754.
77. Rassi, A., Jr, Rassi, A. and Marin-Neto, J. A. (2009). Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Mem. Inst. Oswaldo Cruz 104, 152-158.
78. Rayner, B. S., Hua, S., Sabaretnam, T. and Witting, P. K. (2009). Nitric oxide stimulates myoglobin gene and protein expression in vascular smooth muscle. Biochem. J. 423, 169-177.
79. Reeder, B. J., Svistunenko, D. A., Sharpe, M. A. and Wilson, M. T. (2002). Characteristics and mechanism of formation of peroxide-induced heme to protein cross-linking in myoglobin. Biochemistry 41, 367-375.
80. Rodriguez-Malaver, A. J., Leake, D. S. and Rice-Evans, C. A. (1997). The effects of low-density lipoprotein by copper and metmyoglobin are different. FEBS Lett. 406, 37-41.
81. 2 entry into and exit from myoglobin. J. Biol. Chem. 276, 5177-5188.
82. Shiva, S., Huang, Z., Grubina, R., Sun, J., Ringwood, L. A., Macarthur, P. H., Xu, X., Murphy, E., Darley-Usmar, V. M. and Gladwin, M. T. (2007a). Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ. Res. 100, 654-661.
83. Shiva, S., Sack, M. N., Greer, J. J., Duranski, M., Ringwood, L. A., Burwell, L., Wang, X., McArthur, P. H., Shoja, A., Raghavachari, N. et al. (2007b). Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J. Exp. Med. 204, 2089-2102.
84. Shoenborn, B. P., Watson, H. C. and Kendrew, J. C. (1965). Binding of xenon to sperm whale myoglobin. Nature 207, 28-30.
85. Simon, M. C. (2006). Mitochondrial reactive oxygen species are required for hypoxic HIF alpha stabilization. Adv. Exp. Med. Biol. 588, 165-170.
86. Stenger, S., Donhauser, N., Thuring, H., Rollinghoff, M. and Bogdan, C. (1996). Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 183, 1501-1514.
87. Tachado, S. D., Gerold, P., McConville, M. J., Baldwin, T., Quilici, D., Schwarz, R. T. and Schofield, L. (1996). Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway. J. Immunol. 156, 1897-1907.
88. Taylor, E. R., Hurrell, F., Shannon, R. J., Lin, T. K., Hirst, J. and Murphy, M. P. (2003). Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J. Biol. Chem. 278, 19603-19610.
89. Tilton, R. F., Jr, Kuntz, I. D., Jr and Petsko, G. A. (1984). Cavities in proteins: structure of a metmyoglobin-xenon complex solved to 1.9 A. Biochemistry 23, 2849-2857.
90. Tiravanti, E., Samouilov, A. and Zweier, J. L. (2004). Nitrosyl-heme complexes are formed in the ischemic heart: evidence of nitrite-derived nitric oxide formation, storage, and signaling in post-ischemic tissues. J. Biol. Chem. 279, 11065-11073.
91. Tomita, A., Sato, T., Ichiyanagi, K., Nozawa, S., Ichikawa, H., Chollet, M., Kawai, F., Park, S. Y., Tsuduki, T., Yamato, T. et al. (2009). Visualizing breathing motion of internal cavities in concert with ligand migration in myoglobin. Proc. Natl. Acad. Sci. USA 106, 2612-2616.
92. Ulibarri, J. A., Mozdziak, P. E., Schultz, E., Cook, C. and Best, T. M. (1999). Nitric oxide donors, sodium nitroprusside and S-nitro-N- acetylpencillamine, stimulate myoblast proliferation in vitro. In Vitro Cell. Dev. Biol. Anim. 35, 215-218.
93. van der Meer, D. L. M., van den Thillart, G. E. E. J. M., Witte, F., de Bakker, M. A. G., Besser, J., Richardson, M. K., Spaink, H. P., Leito, J. T. D. and Bagowski, C. P. (2005). Gene expression profiling of the long-term adaptive response to hypoxia in the gills of adult zebrafish. Am. J. Physiol. 289, R1512-R1519.
94. Vaupel, P., Kallinowski, F. and Okunieff, P. (1989). Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 49, 6449-6465.
95. Venturini, G., Colasanti, M., Salvati, L., Gradoni, L. and Ascenzi, P. (2000a). Nitric oxide inhibits falcipain, the Plasmodium falciparum trophozoite cysteine protease. Biochem. Biophys. Res. Commun. 267, 190-193.
96. Venturini, G., Colasanti, M., Salvati, L., Gradoni, L. and Ascenzi, P. (2000b). Nitric oxide inhibits cruzipain, the major papain-like cysteine proteinase from Trypanosoma cruzi. Biochem. Biophys. Res. Commun. 267, 437-441.
97. Vespa, G. N., Cunha, F. Q. and Silva, J. S. (1994). Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect. Immun. 62, 5177-5182.
98. Vuletich, J. L., Osawa, Y. and Aviram, M. (2000). Enhanced lipid oxidation by oxidatively modified myoglobin: role of protein-bound heme. Biochem. Biophys. Res. Commun. 269, 647-651.
99. Wegener, J. W., Gödecke, A., Schrader, J. and Nawrath, H. (2002). Effects of nitric oxide donors on cardiac contractility in wild-type and myoglobin-deficient mice. Br. J. Pharmacol. 136, 415-420.
100. Wittenberg, B. A. and Wittenberg, J. B. (1989). Transport of oxygen in muscle. Annu. Rev. Physiol. 51, 857-878.
101. Wittenberg, J. B. (1970). Myoglobin-facilitated oxygen diffusion: role of myoglobin in oxygen entry into muscle. Physiol. Rev. 50, 559-636.
102. Witting, P. K. and Mauk, A. G. (2001). Reaction of human myoglobin and H2O2. Electron transfer between tyrosine 103phenoxyl radical and cysteine 110 yields a protein-thiyl radical. J. Biol. Chem. 276, 16540-16547.
103. Witting, P. K., Liao, W. Q., Harris, M. J. and Neuzil, J. (2006). Expression of human myoglobin in H9c2 cells enhances toxicity to added hydrogen peroxide. Biochem. Biophys. Res. Commun. 348, 485-493.
104. Wright, T. J. and Davis, R. W. (2006). The effect of myoglobin concentration on aerobic dive limit in a Weddell seal. J. Exp. Biol. 209, 2576-2585.
105. Wunderlich, C., Flögel, U., Gödecke, A., Heger, J. and Schrader, J. (2003). Acute inhibition of myoglobin impairs contractility and energy state of iNOS-overexpressing hearts. Circ. Res. 92, 1352-1358.
106. Wynn, T. A., Oswald, I. P., Eltoum, I. A., Caspar, P., Lowenstein, C. J., Lewis, F. A., James, S. L. and Sher, A. (1994). Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J. Immunol. 153, 5200-5209.
107. Yang, Y. G., Guan, H., Liu, C. W. and Li, Y. J. (2009). Myoglobin over-expression attenuates angiogenic response in hindlimb ischemia in mice. Chin. Med. J. 122, 1056-1060.